Table 3.
Sample | Body Site | Date Isolated | Colony Morphotype | VNTR Profile | Phenotypic Susceptibility |
---|---|---|---|---|---|
patient_1_S1 | Sputum | -166 days | Rough | I | Amikacin-S; Cipro-R; Clarithromycin-R; Doxycycline-R; Augmentin-R |
patient_1_S2 | Lung tissue | 0 days | Rough | I | Amikacin-PR; Cipro-R; Clarithromycin-R; Doxycycline-R; Linezolid-R; Co-trem-R; Cefotaxime-R |
patient_1_S3 | Sputum | 10 days | Smooth | I | n/a |
patient_1_S4 | Sputum | 15 days | Rough | I | n/a |
patient_1_S5 | Pleural fluid | 21 days | Smooth | I | n/a |
patient_1_S6 | Pleural fluid | 38 days | Rough | I* | n/a |
patient_1_S7 | Pleural fluid | 38 days | Rough | I* | n/a |
patient_1_S8 | Pleural fluid | 40 days | Smooth | I* | n/a |
patient_1_S9 | BAL | 42 days | Smooth | I* | n/a |
patient_1_S10 | Pleural fluid | 49 days | Smooth | I* | n/a |
patient_1_S11 | Pleural fluid | 49 days | Smooth | I* | n/a |
patient_1_S12 | Pleural fluid | 49 days | Smooth | I* | n/a |
patient_1_S13 | Chest wound swab | 49 days | Smooth | I / I* | n/a |
patient_1_S14 | Chest wound swab | 49 days | Smooth | I | n/a |
patient_1_S15 | Sputum | 51 days | Smooth | I / I * | n/a |
patient_1_S16 | Chest wound swab | 56 days | Rough | I | n/a |
patient_2_S1 | Sputum | −121 days | Rough | n/a | Amikacin-R; Cipro-R; Clarithromycin-R; Doxycycline-R; Linezolid-R; Co-trem-R; Cefotaxime-R |
patient_2_S2 | Sputum | −81 days | Smooth | I | n/a |
patient_2_S3 | Lymph node tissue | 0 days | Rough | I | n/a |
patient_2_S4 | Lymph node tissue | 0 days | Smooth | n/a | n/a |
patient_2_S5 | Lymph node tissue | 0 days | Rough | I | n/a |
patient_2_S6 | Lung tissue | 0 days | n/a | I | n/a |
patient_2_S7 | Sputum | 14 days | Smooth | n/a | n/a |
patient_2_S8 | BAL | 27 days | Smooth | I | n/a |
patient_2_S9 | Pleural fluid | 33 days | Smooth | I | n/a |
patient_2_S10 | BAL | 41 days | Smooth | I / I* | n/a |
patient_2_S11 | Pleural fluid | 42 days | Smooth | I | n/a |
patient_2_S12 | Pleural fluid | 42 days | Smooth | I | Amikacin-R; Ciprofloxacin-R; Clarithromycin-R; Doxycycline-R; Linezolid-R; Co-trimoxazole-R; Cefoxitin-R; Tobramycin-R; Moxyfloxacin-R |
patient_2_S13 | Drain site swab | 49 days | Smooth | n/a | n/a |
patient_2_S14 | Pleural fluid | 50 days | Smooth | n/a | n/a |
patient_2_S15 | Pleural fluid | 58 days | Smooth | I | n/a |
patient_2_S16 | Pleural fluid | 59 days | Smooth | n/a | n/a |
Dates are relative to the date of transplant for each patient. An asterisk (*) indicates that the VNTR profile differed at 1 locus. Phenotypic susceptibility was available for a minority of isolates.
Abbreviations: BAL, bronchoalveolar lavage; n/a, data not available; -PR, partially resistant; -R, resistant; -S, susceptible; VNTR, variable nucleotide tandem repeat.